Institutional investors that purchased the convertible notes Reported that $TLRY was the only cannabis company in the world that they currently would have invested in because of our history of financial results, the confidence they have in the management team running the company and our strategic plan as well as the strength of our balance sheet. Those same institutional investors are now net long in our stock and assuming they convert the notes into our shares, will increase the percentage of institutional investors in our stock.
The Tilray team was the first in the industry to diversify its cannabis operations with profitable businesses to properly finance itself and consistently deliver on positive EBITDA in a challenging macro-economic climate and cannabis market.